Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tobias Knipper"'
Autor:
Björn H. Schott, Jakob Christian Voetlause, Juliana Lisa Amoah, Alexander Kratzenberg, Michael Belz, Tobias Knipper, Charles Timäus, Carmen Beskow, Catherine M. Sweeney-Reed, Jens Wiltfang, Katrin Radenbach
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
ObjectiveThe treatment of patients with dementia poses a considerable challenge to regional district general hospitals, particularly in rural areas. Here we report the establishment and initial evaluation of a dementia-specific consultation service p
Externí odkaz:
https://doaj.org/article/df4771ab9e1642e583a8f20aedac2695
Autor:
Franc Llorens, Matthias Schmitz, Tobias Knipper, Christian Schmidt, Peter Lange, Andre Fischer, Peter Hermann, Inga Zerr
Publikováno v:
Frontiers in Aging Neuroscience, Vol 9 (2017)
Vascular factors increase the risks of developing Alzheimer's disease (AD) and they contribute to AD pathology. Since amyloid beta (Aβ) deposits can be observed in both diseases, there is an overlap which impedes a clear discrimination and difficult
Externí odkaz:
https://doaj.org/article/76e7f41f3838429580d664d679994dd5
Autor:
Johannes Treig, Markus Glatzel, Inga Zerr, Jakob Matschke, Stefan Goebel, Matthias Schmitz, Tobias Knipper, Peter Hermann, Maria Cramm, Mareike Laux, Walter J. Schulz-Schaeffer
Publikováno v:
Neurology. 91:e331-e338
ObjectiveTo validate an amended protocol for clinical diagnosis of sporadic Creutzfeldt-Jakob disease (sCJD) including real-time quaking-induced conversion (RT-QuIC) and to observe its use in CJD surveillance.MethodsIn the framework of a prospective
Autor:
Matthias Schmitz, Johannes Kornhuber, Piotr Lewczuk, Stefan Goebel, Peter Lange, Natalia Ermann, Franc Llorens, Inga Zerr, Tobias Knipper
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology 5(7), 883-887 (2018). doi:10.1002/acn3.584
Annals of Clinical and Translational Neurology 5(7), 883-887 (2018). doi:10.1002/acn3.584
Creutzfeldt–Jakob disease and Alzheimer's disease are characterized by the presence of elevated total‐Tau cerebrospinal fluid concentrations while the presence of hyperphosphorylated Tau forms in the cerebrospinal fluid is rather a hallmark of Al
Autor:
Michael D. Geschwind, Christiane Stehmann, Janna Kenny, Sabina Capellari, Ryusuke Ae, Sonia M Vallabh, Leonel T. Takada, Masahito Yamada, Piero Parchi, Tadashi Tsukamoto, Steven J. Collins, Jamie Fong, Nobuo Sanjo, Claudia Ponto, Jean Louis Laplanche, Inga Zerr, Tobias Knipper, Jean Philippe Brandel, Margaret C. Orseth, Peter Hermann, Yosikazu Nakamura, Simon Mead, Stéphane Haïk, Miguel Calero, Tetsuyuki Kitamoto, Tsuyoshi Hamaguchi, Jesús de Pedro-Cuesta, Ignazio Roiter, Roberto Chiesa, Eric Vallabh Minikel, Jiri G. Safar, Hidehiro Mizusawa
Publikováno v:
Neurology
ObjectiveTo determine whether preventive trials in genetic prion disease could be designed to follow presymptomatic mutation carriers to onset of disease.MethodsWe assembled age at onset or death data from 1,094 individuals with high penetrance mutat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df677495b8ccff64cb7a8d32192e8a0
http://hdl.handle.net/11585/695188
http://hdl.handle.net/11585/695188
Autor:
Piero Parchi, Hidehiro Mizusawa, Claudia Ponto, Nobuo Sanjo, Janna Kenny, Inga Zerr, Jean Louis Laplanche, Tobias Knipper, Miguel Calero, Jiri G. Safar, Yosikazu Nakamura, Stéphane Haïk, Simon Mead, Sabina Capellari, Leonel T. Takada, Ignazio Roiter, Christiane Stehmann, Tadashi Tsukamoto, Sonia M Vallabh, Jamie Fong, Tsuyoshi Hamaguchi, Masahito Yamada, Margaret C. Orseth, Eric Vallabh Minikel, Steven J. Collins, Michael D. Geschwind, Ryusuke Ae, Tetsuyuki Kitamoto, Jean Philippe Brandel, Peter Hermann, Roberto Chiesa, Jesús de Pedro-Cuesta
Regulatory agencies worldwide have adopted programs to facilitate drug development for diseases where the traditional approach of a randomized trial with a clinical endpoint is expected to be prohibitively lengthy or difficult. Here we provide quanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c8e0da008f2620b8cef736431dd9277
https://doi.org/10.1101/401406
https://doi.org/10.1101/401406
Autor:
Beata Sikorska, Anna Ladogana, Isabel Santana, Pawel P. Liberski, Stefan Goebel, Kaj Blennow, Daniela Varges, Aikaterini Karsanidou, Eirini Kanata, Theodoros Sklaviadis, André Karch, Inês Baldeiras, Isidro Ferrer, Daniela Diaz-Lucena, Franc Llorens, Inga Zerr, Ewa Golanska, Tobias Knipper, Raquel Sánchez-Valle, Matthias Schmitz, Peter Hermann, Henrik Zetterberg, Anna Villar-Piqué, Miguel Calero, Olga Calero
Publikováno v:
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Alzheimer's and dementia 14(6), 751-763 (2018). doi:10.1016/j.jalz.2017.12.008
Alzheimer's & Dementia
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Alzheimer's and dementia 14(6), 751-763 (2018). doi:10.1016/j.jalz.2017.12.008
Alzheimer's & Dementia
Introduction Neurofilament light (NFL) levels in the cerebrospinal fluid are increased in several neurodegenerative dementias. However, their diagnostic accuracy in the differential diagnostic context is unknown. Methods Cerebrospinal fluid NFL level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd641d4a66e22a41176ed74e23d0128a
http://hdl.handle.net/2445/137381
http://hdl.handle.net/2445/137381
Autor:
André Karch, Beata Sikorska, Nadine Gotzmann, Pawel P. Liberski, Inga Zerr, Tobias Knipper, Brit Mollenhauer, Niels Kruse, Franc Llorens, Ting Sun, Saima Zafar, Ewa Golanska, Raquel Sánchez-Valle, Matthias Schmitz, Maria Cramm, Silja Köchy, Andre Fischer
Publikováno v:
Molecular Neurobiology
Molecular neurobiology 55(3), 2249-2257 (2018). doi:10.1007/s12035-017-0479-5
Molecular neurobiology 55(3), 2249-2257 (2018). doi:10.1007/s12035-017-0479-5
The analysis of cerebrospinal fluid (CSF) biomarkers gains importance in the differential diagnosis of prion diseases. However, no single diagnostic tool or combination of them can unequivocally confirm prion disease diagnosis. Electrochemiluminescen